Market Place
Sourcing Support
Renaissance Lakewood Completes Campus Enhancement Project
03 Sep 2024 //
CONTRACT PHARMA
Renaissance Opens New HQ Global Cdmo Makes Addi. Invet In Ocean County,Nj Campus
14 May 2024 //
PRESS RELEASE
The role of CDMOs in overcoming nasal drug delivery R&D & Mfg challenges
24 Apr 2024 //
PRESS RELEASE
Q&A with European Pharmaceutical Manufacturer Magazine
23 Apr 2024 //
PRESS RELEASE
Essential Pharma Acquires Renaissance for Neuroblastoma Therapy.
09 Apr 2024 //
GLOBENEWSWIRE
Essential completes acquisition of Renaissance its clinical stage immunotherapy
09 Apr 2024 //
PHARMABIZ
Renaissance Lakewood Excels In Nasal Product R&D And Clinical Manufacturing
14 Feb 2024 //
PRESS RELEASE
Renaissance Pharma launches today & announces the in-licensing of Hu14.18K322A
01 Aug 2023 //
GLOBENEWSWIRE
Renaissance Lakewood Invests in Additional High-Speed Nasal Spray Assembly Capability
05 Apr 2023 //
CONTRACT PHARMA
The Renaissance of Small Molecule Drug Discovery
03 Aug 2022 //
CONTRACTPHARMA
Renaissance SSA`s Generic Naloxone Hydrochloride Receives Approval in US
17 Dec 2018 //
FDA
Renaissance`s Generic Dicyclomine Hydrochloride Receives Approval in US
15 Nov 2018 //
FDA
Renaissance`s Generic Neostigmine Methylsulfate Receives Approval in US
24 Aug 2018 //
FDA
Renaissance’s Generic Sodium Nitroprusside Receives Approval In US
29 Jun 2018 //
FDA
Renaissance’s Generic Succinylcholine Chloride Receives Approval In US
07 Jun 2018 //
FDA
Enforcement Report - Week of April 25, 2018
25 Apr 2018 //
FDA
Enforcement Report - Week of December 27, 2017
27 Dec 2017 //
FDA
Renaissance’s Generic Pentobarbital Sodium Receives Approval In US
29 Nov 2017 //
FDA
Renaissance’s Generic Oxacillin Sodium Receives Approval In US
13 Sep 2017 //
FDA
Renaissance’s Generic Mesalamine Receives Approval In US
26 Aug 2017 //
FDA
Renaissance`s Generic Methocarbamol Receives Approval In US
19 Jan 2017 //
FDA
Hillary Clinton`s medical condition May be taking dangerous drug Levaquin
15 Sep 2016 //
PR NEWSWIRE
Mylan Completes Acquisition of Renaissance`s Leading Topicals
16 Jun 2016 //
PR NEWSWIRE
German Drugmakers Appeal Drug Suspensions Linked to Indian Data
15 Dec 2014 //
REUTERS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.